Since March 2020, the inclusions of new patients, apart from studies on Covid, were slowing down and the majority of patients monitored no longer came to the hospital.
Since the start of the pandemic, research concerning Covid has mobilized researchers and the public passionate about it. In France, more than a hundred clinical trials devoted to this emergency have been carried out or launched. But alongside this very understandable craze, the pandemic has also put a serious brake on clinical research on all other subjects … “During the first wave, the majority of clinical trials were stopped. We only continued the trials that it was impossible to suspend, such as those concerning cancer ”, explains the Pr Antoine Magnan, research advisor for the General Directorate of Healthcare Provision (DGOS) and pulmonologist at Foch Hospital in Suresnes. No wonder: clinical research, an essential activity for evaluating drugs but also new medical techniques, takes place overwhelmingly in university hospital centers (CHU) which have been at the heart of the fight against the epidemic. and oriented
This article is for subscribers only. You have 81% left to discover.
Pushing back the limits of science is also freedom.
Continue reading your article for € 1 the first month
Already subscribed? Log in